ESR1 and breast neoplasm: In a previous study, the expression of GST-π was investigated in 21 primary untreated human breast tumors (16) and in agreement with the findings of the present study, the mean expression of GST-π in ER-negative tumors was found to be 5-fold greater than the mean expression in ER-positive tumors.